135 related articles for article (PubMed ID: 28824272)
21. Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate.
Fabresse N; Devictor B; Pissier C; Chambost H; Lacarelle B; Michel G; Solas C
Ther Drug Monit; 2018 Feb; 40(1):76-83. PubMed ID: 29120974
[TBL] [Abstract][Full Text] [Related]
22. A simple, rapid and reliable liquid chromatography-mass spectrometry method for determination of methotrexate in human plasma and its application to therapeutic drug monitoring.
Wu D; Wang Y; Sun Y; Ouyang N; Qian J
Biomed Chromatogr; 2015 Aug; 29(8):1197-202. PubMed ID: 25641007
[TBL] [Abstract][Full Text] [Related]
23. Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for monitoring methotrexate in the setting of carboxypeptidase-G2 therapy.
Kumar VS; Law T; Kellogg M
Methods Mol Biol; 2010; 603():359-63. PubMed ID: 20077087
[TBL] [Abstract][Full Text] [Related]
24. Sensitive and rapid high-performance liquid chromatographic method for the simultaneous determination of methotrexate and its metabolites in plasma, saliva and urine.
Chen ML; Chiou WL
J Chromatogr; 1981 Nov; 226(1):125-34. PubMed ID: 7320138
[TBL] [Abstract][Full Text] [Related]
25. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous determination of methotrexate and its polyglutamate metabolites in Caco-2 cells by liquid chromatography-tandem mass spectrometry.
Chen G; Fawcett JP; Mikov M; Tucker IG
J Pharm Biomed Anal; 2009 Sep; 50(2):262-6. PubMed ID: 19473804
[TBL] [Abstract][Full Text] [Related]
27. Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry.
Matthews CZ; Woolf EJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):36-45. PubMed ID: 18249589
[TBL] [Abstract][Full Text] [Related]
28. A validated LC-MS/MS assay for simultaneous quantification of methotrexate and tofacitinib in rat plasma: application to a pharmacokinetic study.
Sharma K; Giri K; Dhiman V; Dixit A; Zainuddin M; Mullangi R
Biomed Chromatogr; 2015 May; 29(5):722-32. PubMed ID: 25298296
[TBL] [Abstract][Full Text] [Related]
29. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
Chavez-Eng CM; Lutz RW; Li H; Goykhman D; Bateman KP; Woolf E
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():204-14. PubMed ID: 26773885
[TBL] [Abstract][Full Text] [Related]
30. Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader.
Widemann BC; Balis FM; Adamson PC
Clin Chem; 1999 Feb; 45(2):223-8. PubMed ID: 9931044
[TBL] [Abstract][Full Text] [Related]
31. Determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N10-methylpteroic acid in biological fluids by liquid chromatography with fluorimetric detection.
Salamoun J; Frantisek J
J Chromatogr; 1986 May; 378(1):173-81. PubMed ID: 3733970
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.
Milano G; Thyss A; Renee N; Schneider M; Namer M; Boublil JL; Lalanne CM
Cancer Chemother Pharmacol; 1983; 11(1):29-32. PubMed ID: 6883624
[TBL] [Abstract][Full Text] [Related]
33. A simple preparation of the methotrexate metabolites 7-hydroxymethotrexate and 4-deoxy-4-amino-N10-methylpteroic acid.
Cairnes DA; Evans WE
Ther Drug Monit; 1983; 5(3):363-6. PubMed ID: 6636263
[TBL] [Abstract][Full Text] [Related]
34. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children.
Winograd B; Lippens RJ; Oosterbaan MJ; Dirks MJ; Vree TB; van der Kleijn E
Eur J Clin Pharmacol; 1986; 30(2):231-8. PubMed ID: 3709652
[TBL] [Abstract][Full Text] [Related]
35. Determination of 7-hydroxymethotrexate in human plasma by reversed phase high-performance liquid chromatography.
Erttmann R; Bielack S; Landbeck G
Oncology; 1986; 43(2):86-8. PubMed ID: 3456549
[TBL] [Abstract][Full Text] [Related]
36. High-throughput assay for quantification of the plasma concentrations of thiopental using automated solid phase extraction (SPE) directly coupled to LC-MS/MS instrumentation.
Moosavi SM; Shekar K; Fraser J; Smith MT; Ghassabian S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():80-87. PubMed ID: 27802918
[TBL] [Abstract][Full Text] [Related]
37. LC-MS-MS determination of nemorubicin (methoxymorpholinyldoxorubicin, PNU-152243A) and its 13-OH metabolite (PNU-155051A) in human plasma.
Fraier D; Frigerio E; Brianceschi G; James CA
J Pharm Biomed Anal; 2002 Oct; 30(3):377-89. PubMed ID: 12367663
[TBL] [Abstract][Full Text] [Related]
38. Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review.
Silva MF; Ribeiro C; Gonçalves VMF; Tiritan ME; Lima Á
Biomed Chromatogr; 2018 May; 32(5):e4159. PubMed ID: 29226354
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a HPLC-MS/MS method for the determination of phytolaccagenin in rat plasma and application to a pharmacokinetic study.
Wei F; Singh RS; Fueth M; Swarts S; Okunieff P; Derendorf H
J Pharm Biomed Anal; 2015 Mar; 107():82-8. PubMed ID: 25575173
[TBL] [Abstract][Full Text] [Related]
40. Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples.
Karami F; Ranjbar S; Ghasemi Y; Negahdaripour M
J Pharm Anal; 2019 Dec; 9(6):373-391. PubMed ID: 31890337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
